Merck & Co

DividendsMerck & Co

MRK

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
9/15/2025
10/7/2025
0,81
Quarterly
6/16/2025
7/8/2025
0,81
Quarterly
3/17/2025
4/7/2025
0,81
Quarterly
12/16/2024
1/8/2025
0,81
Quarterly
9/16/2024
10/7/2024
0,77
Quarterly
6/17/2024
7/8/2024
0,77
Quarterly
3/14/2024
4/5/2024
0,77
Quarterly
12/14/2023
1/8/2024
0,77
Quarterly
9/14/2023
10/6/2023
0,73
Quarterly
6/14/2023
7/10/2023
0,73
Quarterly
3/14/2023
4/10/2023
0,73
Quarterly
12/14/2022
1/9/2023
0,73
Quarterly
9/14/2022
10/7/2022
0,69
Quarterly
6/14/2022
7/8/2022
0,69
Quarterly
3/14/2022
4/7/2022
0,69
Quarterly
12/14/2021
1/7/2022
0,69
Quarterly
1/10